Declaration on the Effectiveness of Bioperfectus SARS-CoV-2 Antigen Rapid Test Kit against New Variant Omicron

Company news
2021-12-02

The spread of the new variant “Omicron” is faster than expected. The countries and regions with reported Omicron cases on the GISAID website have been increased to twenty-one on Dec. 2, 2021. The data only showed the number of submitted sequenced cases, which might be just the tip of the iceberg.

 

 

Source: https://www.gisaid.org/hcov19-variants/

 

 

Facing this more contagious variant, not only our real-time PCR kits but also our antigen rapid test kit stay reliable and effective. After an in-silico analysis and simulation experiment with recombinant proteins, although the Omicron has mutation sites on the Nucleocapsid Protein of SARS-CoV-2, there is no influence on the detection region of Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit. Therefore, our kit effectively shows no drop-off in sensitivity and specificity in face of the Omicron variant.

 

 

 

 

 

MOST READ

Bioperfectus Obtained CE Mark for the SARS-CoV-2 Antigen Rapid Self-test

Bioperfectus is pleased to announce that we have obtained CE Mark for our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test).

2021-12-28

Bioperfectus Launches a New RT-PCR Kit to Detect COVID-19 New Variant"Omicron"

As a leading manufacturer of molecular diagnostic solutions for infectious diseases, Biopertectus is very proud to announce today that the new SARS-CoV-2 Variant Omicron (B.1.1.529) Real-Time PCR Kit is launched globally. With the detection of the mutation sites of H655Y, N679K, P681H, and E484A, this new kit could help to identify the Omicron variant conveniently and effectively.

2021-12-27

Bioperfectus Whole Blood DNA Extraction Kit is Available Now!

We are proud to inform you that a new member is joining in Bioperfectus extraction solution pipeline.

2021-12-06